Lv. Rizzo et al., INTERLEUKIN-2 TREATMENT POTENTIATES INDUCTION OF ORAL TOLERANCE IN A MURINE MODEL OF AUTOIMMUNITY, The Journal of clinical investigation, 94(4), 1994, pp. 1668-1672
The present study addresses the feasibility of potentiating oral toler
ance by immunomanipulation, using the murine model of experimental aut
oimmune uveoretinitis (EAU) induced by immunization with the retinal a
ntigen interphotoreceptor retinoid binding protein (IRBP). Three feedi
ngs of 0.2 mg IRBP every other day before immunization did not protect
against EAU, whereas a similar regimen of five doses was protective.
However, supplementing the nonprotective 3X regimen with as little as
one injection of 1,000 U of human recombinant interleukin-2 (IL-2) res
ulted in disease suppression that was equal to that of the protective
5X regimen. The protective effect was maintained across a range of IL-
2 doses and times of administration; none of the IL-2 regimens tested
resulted in disease enhancement. Peyer's Patch cells of 3X-fed and IL-
2-treated mice showed greatly increased production of TGF-beta, IL-4,
and IL-10 compared with animals given the nonprotective 3X regimen and
to animals given the protective 5X regimen. We propose that IL-2 trea
tment enhances protection from EAU at least in part by stimulating pro
duction of antiinflammatory cytokines by regulatory cells in Payer's P
atches. Moreover, the observed lymphokine production patterns suggest
that whereas protection induced by the 3X + IL-2 regimen is likely to
involve antiinflammatory cytokines, protection induced by the 5X regim
en might involve anergy or deletion of the uveitogenic T cells. These
results could have practical implications for use of IL-2 as a safe an
d effective way of potentiating oral tolerance.